Trials / Completed
CompletedNCT00859287
Omepral® Tablets Special Clinical Experience Investigation in Patients With Erosive Esophagitis
Omepral® Tablets Mega-study to Investigate the Efficacy on Various Type of Acid Reflux Related Symptoms and QOL, and Epidemiology in Patients With Erosive Esophagitis in Daily Medical Practice
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 10,703 (actual)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This open label, non-interventional study is to compare the efficacy of Omepral® tablet and any other treatments excepting proton pump inhibitors (PPIs) for the treatment of various type of acid reflux related symptoms in patients with reflux esophagitis.
Conditions
Timeline
- Start date
- 2007-06-01
- Completion
- 2008-07-01
- First posted
- 2009-03-11
- Last updated
- 2009-07-15
Source: ClinicalTrials.gov record NCT00859287. Inclusion in this directory is not an endorsement.